As Brexit approaches, Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, continues to evaluate and prepare for the impact of the United Kingdom’s (UK) withdrawal from the European Union (EU) on our operations. Since 2018, we have undertaken significant mitigation efforts to maintain the continued supply of our products to patients and customers without disruption.

While government negotiations continue, we are actively planning for several scenarios and the various potential impacts each may have on our business, including supply chain and customs implications, and have also worked extensively to transition regulatory authorizations to help ensure our products continue to reach those who need them.

Throughout this transition, we remain committed to meeting the needs of our customers and patients with our trusted solutions.